Welcome to our dedicated page for Hanover Insuranc SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hanover Insurance Group, Inc. (NYSE: THG) is an SEC-reporting holding company for several property and casualty insurance subsidiaries. This page provides access to the company’s U.S. Securities and Exchange Commission filings, which document its regulatory and financial reporting as a public insurer. These filings are a primary source for understanding The Hanover’s capital structure, debt issuance, financial results, and other material events.
Among the key documents are current reports on Form 8-K, where The Hanover discloses significant developments. Recent 8-K filings describe the issuance of senior unsecured notes due 2035, the planned use of proceeds to repay existing debentures and notes and for general corporate purposes, and the call for redemption of 4.500% notes due 2026. Another 8-K furnishes the company’s quarterly financial results and references an accompanying financial supplement made available on its website.
Filings also include a Form 25 submitted by the New York Stock Exchange relating to the removal from listing and registration of a specific class of 7 5/8% senior debentures due 2025. The same filing identifies The Hanover’s common stock as listed on the New York Stock Exchange under the symbol THG. Together, these documents outline how the company manages its publicly traded securities and complies with exchange and SEC requirements.
On Stock Titan, investors can use AI-powered tools to review these filings, with real-time updates from EDGAR and summaries that explain the significance of items such as 8-K disclosures and Form 25 notices. This helps users quickly understand how The Hanover reports its financial condition, capital actions, and other material information within the regulatory framework for U.S. public companies.
The Hanover Insurance Group, Inc. entered into an underwriting agreement to sell $500 million aggregate principal amount of its 5.500% Notes due 2035. The offering was underwritten by Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as representatives of the several underwriters. The Notes were registered on Form S-3 and issued under the companys Base Indenture dated April 8, 2016, as supplemented by a Third Supplemental Indenture dated August 21, 2025. U.S. Bank Trust Company National Association (successor in interest to U.S. Bank National Association) is the trustee. Exhibits include the Underwriting Agreement, the Indenture and Third Supplemental Indenture, the form of security certificate, legal opinion and consent from Ropes & Gray LLP, and a company press release.
The Hanover Insurance Group, Inc. filed an S-3ASR registration statement for securities, incorporating prior SEC filings and standard exhibits. The filing lists corporate governance documents including an Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws incorporated by reference, forms for indenture, warrants, preferred stock certificates and depositary/rights agreements, and legal and auditor consents from Ropes & Gray LLP and PricewaterhouseCoopers LLP. The document references provisions that may limit stockholder actions—including supermajority vote thresholds and restrictions on written consents and special meetings—and notes tax treatment language for original issue discount (zero-coupon) debt securities to be detailed in prospectus supplements. The filing includes signature blocks dated August 18, 2025.
The Hanover Insurance Group, Inc. (THG) filed a Form 144 indicating the intent of an insider to sell up to 5,626 common shares on or after 08/01/2025 through Fidelity Brokerage Services on the NYSE. The proposed sale represents roughly 0.016 % of THG’s 35.8 million shares outstanding and carries an aggregate market value of about $946,033.
The shares were acquired via the exercise of stock options granted on 02/28/2020, with cash used to cover the purchase price on the same date as the planned sale (08/01/2025). The filer reported no other THG share sales in the past three months. As required, the filer certifies not to possess undisclosed material adverse information about the company.
While the transaction is modest relative to THG’s float, Form 144 signals potential insider supply entering the market, which some investors may view as a short-term negative sentiment indicator.
FAQ
What is the current stock price of Hanover Insuranc (THG)?
What is the market cap of Hanover Insuranc (THG)?
